Chromadex Corp Stock
Chromadex Corp Stock
The Chromadex Corp stock is trending slightly upwards today, with an increase of €0.020 (0.630%) compared to yesterday's price.
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 5 € shows a very positive potential of 58.23% compared to the current price of 3.16 € for Chromadex Corp.
For the coming years our community has positive and negative things to say abot the Chromadex Corp stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -42.545% | - |
| Organovo Holdings Inc. | 1.620% | -1.682% | -8.071% | -47.422% | -14.522% | -84.011% | -94.977% |
| Intellia Therapeutics Inc | 0.980% | 6.990% | 3.241% | -41.001% | -18.584% | -52.220% | 65.869% |
| VBI Vaccines Inc. | 2.890% | 5.176% | 2.893% | -79.894% | 7.358% | -99.214% | -98.935% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat